[Federal Register Volume 68, Number 19 (Wednesday, January 29, 2003)]
[Notices]
[Pages 4492-4493]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-1974]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60 Day-03-38]


Proposed Data Collections Submitted for Public Comment and 
Recommendations

    In compliance with the requirement of Section 3506(c)(2)(A) of the 
Paperwork Reduction Act of 1995 for opportunity for public comment on 
proposed data collection projects, the Centers for Disease Control and 
Prevention (CDC) will publish periodic summaries of proposed projects. 
To request more information on the proposed projects or to obtain a 
copy of the data collection plans and instruments, call the CDC Reports 
Clearance Officer on (404) 498-1210.
    Comments are invited on: (a) Whether the proposed collection of 
information is necessary for the proper performance of the functions of 
the agency, including whether the information shall have practical 
utility; (b) the accuracy of the agency's estimate of the burden of the 
proposed collection of information; (c) ways to enhance the quality, 
utility, and clarity of the information to be collected; and (d) ways 
to minimize the burden of the collection of information on respondents, 
including through the use of automated collection techniques or other 
forms of information technology. Send comments to Anne O'Connor, CDC 
Assistant Reports Clearance Officer, 1600 Clifton Road, MS-D24, 
Atlanta, GA 30333. Written comments should be received within 60 days 
of this notice.
    Proposed Project: Reporting Requirements for Assessment of the 
Well-Integrated Screening and Evaluation for Women Across the Nation 
(WISEWOMAN)--New--National Center for Chronic Disease Prevention and 
Health Promotion (NCCDPHP), Centers for Disease Control and Prevention 
(CDC).

Background

    The WISEWOMAN program, which focuses on reducing cardiovascular 
disease risk factors among at-risk women, was in response to the 
Secretary of Health and Human Services' Continuous Improvement 
Initiative, asking for the development of programs that examine ways in 
which service delivery can be improved for select populations. Title XV 
of the Public Health Service Act, Section 1509 originally authorized 
the secretary of the Department of Health and Human Services to 
establish up to three demonstration projects. Through appropriations 
language, the CDC WISEWOMAN program is now allowed to fund up to 15 
projects. Currently, WISEWOMAN funds 12 demonstration projects, which 
at full implementation are expected to screen approximately 30,000 
women annually for cardiovascular disease risk factors. The program 
targets women already participating in the National Breast and Cervical 
Cancer Early Detection Program (NBCCEDP) and provides screening for 
select cardiovascular disease risk factors (including elevated 
cholesterol, hypertension, and abnormal blood glucose levels), 
lifestyle interventions, and medical referrals as required in an effort 
to improve cardiovascular health among participants.
    The CDC proposes to collect and analyze baseline and follow-up data 
(12 months post enrollment) for all participants. These data, called 
the minimum data elements (MDE's), includes demographic and risk factor 
information about women served in each program and information 
concerning the number and type of intervention sessions attended. The 
MDE data allows for an assessment of how effective WISEWOMAN is at 
reducing the burden of cardiovascular disease risk factors among 
participants. The CDC also proposes to collect programmatic data for 
all WISEWOMAN programs. Programmatic data includes information related 
to grantee management, public education and outreach, professional 
education, service delivery, cost, and an assessment of how well each 
program is meeting their stated objectives.
    All required data will be submitted electronically to RTI 
International, the contractor hired by CDC to conduct the WISEWOMAN 
evaluation. MDE and cost data will be submitted to RTI twice a year, 
October 15 and April 15. October 15 reporting will cover all MDE's and 
costs for activities that took place between January 1 and June 30, and 
the April 15 submission will cover MDE's and costs for activities 
occurring between July 1 and December 31. Quarterly reports containing 
programmatic data will be due to RTI on January 31 (reflecting October 
1-December 31 program activities), April 30 (reflecting January 1-March 
31), July 31 (reflecting April 1-June 30), and October 31 (reflecting 
July 1-September 30). All reports will be due in a pre-determined 
format provided by CDC and the contractor. The contractor will provide 
training as requested to WISEWOMAN personnel at each location 
concerning data collection and submission.
    All information collected as part of the WISEWOMAN evaluation will 
be used to assess the costs, effectiveness, and cost-effectiveness of 
WISEWOMAN in reducing cardiovascular disease risk factors, for 
obtaining more complete health data among vulnerable populations, 
promoting public education of disease incidence and risk-factors, 
improving the availability of screening and diagnostic services for 
under-served women, ensuring the quality of services provided to women, 
and developing strategies for improved interventions. Because certain 
demographic data are already collected as part of NBCCEDP, the 
additional burden on grantees will be modest. Once the infrastructure 
is established to capture the additional WISEWOMAN data, the response 
burden is expected to be reduced even further. There are no costs to 
respondents.

[[Page 4493]]



----------------------------------------------------------------------------------------------------------------
                                                                     Number of    Average burden
                      Form                           Number of     responses per   per response    Total burden
                                                    respondents     respondent      (in hours)      (in hours)
----------------------------------------------------------------------------------------------------------------
Screening MDE Report............................              12               2              16             384
Intervention MDE Report.........................              12               2               8             192
Cost Report.....................................              12               2              16             384
Quarterly Report................................              12               4              16             768
                                                 -----------------
    Total.......................................  ..............  ..............  ..............            1728
----------------------------------------------------------------------------------------------------------------


    Dated: January 21, 2003.
Thomas Bartenfeld,
Acting Associate Director for Policy, Planning and Evaluation Centers 
for Disease Control and Prevention.
[FR Doc. 03-1974 Filed 1-28-03; 8:45 am]
BILLING CODE 4163-18-P